SCHEMBL12099232

SCHEMBL12099232

C1=C\CC/C=C\CC/1.C1=C\CC/C=C\CC/1.[Rh].[Rh]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5270631 1.00
SCHEMBL3847589 1.00
SCHEMBL3868877 1.00
SCHEMBL529741 1.00
SCHEMBL15789750 1.00
SCHEMBL4959158 1.00
SCHEMBL5270632 1.00
Hydrochloric Acid SCHEMBL8392520 0.94
SCHEMBL6632474 0.94
Hydrochloric Acid SCHEMBL8392525 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2443129-B1 PROCESS FOR HYDROGENATION OF HALOGENOALKENES WITHOUT DEHALOGENATION LEK PHARMACEUTICALS (SI) 2016-11-23 EP claimed
US-8785674-B2 Process for hydrogenation of halogenoalkenes without dehalogenation LEK PHARMACEUTICALS D.D. (SL) 2014-07-22 US claimed
EP-2427419-B1 VINYL ESTER PRODUCTION FROM ACETYLENE AND CARBOXYLIC UTILIZING HOMOGENEOUS CATALYST CELANESE INT CORP (US) 2014-06-18 EP claimed
US-20120231993-A1 NEW SYNTHETIC ROUTE FOR THE PREPARATION OF ALPHA-AMINO BORONIC ACID DERIVATIVES via SUBSTITUTED ALK-1-YNES LEK PHARMACEUTICALS D.D. (SI) 2012-09-13 US claimed
US-9073956-B1 Dihydro-1H-phosphole 1-oxide derivatives and preparation method thereof KNU-INDUSTRY COOPERATION FOUNDATION (KR) 2015-07-07 US disclosed
US-8785674-B2 Process for hydrogenation of halogenoalkenes without dehalogenation LEK PHARMACEUTICALS D.D. (SL) 2014-07-22 US disclosed
US-20120231993-A1 NEW SYNTHETIC ROUTE FOR THE PREPARATION OF ALPHA-AMINO BORONIC ACID DERIVATIVES via SUBSTITUTED ALK-1-YNES LEK PHARMACEUTICALS D.D. (SI) 2012-09-13 US disclosed